Concepedia
European Journal of Pharmacology · 2016 · 33 citations · 9 references
MedicineOncologyPharmacologyCancer PharmacologyCarcinogenesisChemotherapyChemotherapy ResistanceCytotoxic ChemotherapyPharmacodynamics Of Anticancer AgentsCyclooxygenase InhibitorsCyclooxygenase PathwaysCyclooxygenase TargetsGastric Cancer Pharmacotherapy
9
Synergistic anticancer activity of triptolide combined with cisplatin enhances apoptosis in gastric cancer in vitro and in vivo
Chia‐Jung Li, Ching-Yu Chu, Lin-Huang Huang et al. · Cancer Letters · 2012 · 104 citations
Medicine, Oncology, Pharmacology +16
Cyclooxygenase-2, P-glycoprotein-170 and drug resistance; is chemoprevention against multidrug resistance possible?
D Ratnasinghe, Phil Daschner, Miriam R. Anver et al. · PubMed · 2001 · 88 citations
Medicine, Oncology, Pharmacology +13
Imatinib-resistant K562 cells are more sensitive to celecoxib, a selective COX-2 inhibitor: Role of COX-2 and MDR-1
Kalle M. Arunasree, Karnati R. Roy, Kotha Anilkumar et al. · Leukemia Research · 2008 · 65 citations
Medicine, Oncology, Pharmacology +4
Bcr–Abl-independent mechanism of resistance to imatinib in K562 cells: Induction of cyclooxygenase-2 (COX-2) by histone deacetylases (HDACs)
Arunasree M. Kalle, Sachchidanand Sachchidanand, Pallu Reddanna · Leukemia Research · 2010 · 27 citations
Life Sciences, Cell Biology, Molecular Biology +14
Celecoxib antagonizes the cytotoxic effect of cisplatin in human gastric cancer cells by decreasing intracellular cisplatin accumulation
Minghui Chen, Le Yu, Chunping Gu et al. · Cancer Letters · 2012 · 24 citations
Medicine, Oncology, Pharmacology +9